A Conversation with an MPN Specialist: What You Should Know About JAK Inhibitors/Non-JAK Inhibitors

MPN Advocacy & Education International hosted a webinar with Dr. Prithviraj Bose, The University of Texas MD Anderson Cancer Center, as he discussed the major differences between current and upcoming JAK Inhibitors and Non-JAK Inhibitors for MPNs.

[WilliamS-shet]

Although the presentation was detailed, some of the identified drug names (via closed captioned) were Not understandable. Further, when the representative from MD Anderson was referencing, for example platelet count of 50 or 100 or 500, etc., It is difficult to understand the context without a reference range. Is the reference range the 'standard CBC range of 150 to 400 platelets per deciliter of blood?